Biomerica (BMRA) EBT Growth (1y) (2011 - 2026)
Biomerica (BMRA) EBT Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -29.12% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 53.94% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 45.44% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 12.65% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 29.89% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 31.69% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 13.05% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 71.38% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 17.94% |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 | -11.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -11.74% |
| Nov 30, 2025 | -37.99% |
| Aug 31, 2025 | 100.38% |
| May 31, 2025 | -8.84% |
| Feb 28, 2025 | 39.03% |
| Nov 30, 2024 | 36.42% |
| Aug 31, 2024 | -18.30% |
| May 31, 2024 | 20.52% |
| Feb 29, 2024 | -18.51% |
| Nov 30, 2023 | 7.75% |
| Aug 31, 2023 | 46.43% |
| May 31, 2023 | -1.71% |
| Feb 28, 2023 | -1,491.45% |
| Nov 30, 2022 | -44.72% |
| Aug 31, 2022 | -34.98% |
| May 31, 2022 | -2.31% |
| Feb 28, 2022 | 95.23% |
| Nov 30, 2021 | 34.13% |
| Aug 31, 2021 | 18.91% |
| May 31, 2021 | -109.17% |